Recombinant Botulinum Neurotoxin Type D Light Chain, CF

Catalog #: 6037-ZN Datasheet / COA / SDS

Catalog #	Availability	Size / Price	Qty
6037-ZN-010

R&D Systems Recombinant Proteins and Enzymes

1 Image

All BoNT-D Light Chain Proteins and Enzymes

Product Details

Supplemental Products

Reviews

Summary Product Datasheets Carrier Free Data Images Reconstitution Calculator Background Related Research Areas

Recombinant Botulinum Neurotoxin Type D Light Chain, CF Summary

Product Specifications

Purity

>90%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain at 5 μg per lane

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

Activity

Measured by the cleavage of the substrate GFPuv/SNAP/VAMP in a gel-shift assay. >50% of 1 μg substrate is cleaved by 4 ng, as measured under the decribed conditions.

Source

E. coli-derived c. botulinum BoNT-D Light Chain protein
Thr2-Ser428, with an N-terminal Met and 6-His tag

Accession #

P19321

N-terminal Sequence
Analysis

Met

Predicted Molecular Mass

50 kDa

SDS-PAGE

41-45 kDa, reducing conditions

Product Datasheets

6037-ZN

Product Datasheet

COA

SDS

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

6037-ZN

Formulation	Supplied as a 0.2 μm filtered solution in Tris, NaCl, Tween® and Glycerol.
Shipping	The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage:	Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20 to -70 °C as supplied. 3 months, -20 to -70 °C under sterile conditions after opening.

Assay Procedure

Materials

Assay Buffer: 50 mM HEPES, pH 6.5
Recombinant C. botulinum BoNT‑D Light Chain (rBoNT/D-LC) (Catalog # 6037-ZN)
Substrate: Recombinant GFP/SNAP25B/VAMP-2 (Catalog # 7375-SV)
SDS-PAGE and silver stain reagents or equivalent or Western blot with appropriate antibodies

Dilute Substrate to 100 µg/mL in Assay Buffer.
Dilute rBoNT/D-LC to 0.4 µg/mL in Assay Buffer.
Combine equal volumes of diluted Substrate with diluted rBoNT/D-LC. Prepare two controls by combining equal volumes of diluted Substrate with Assay Buffer.
Incubate reaction vials at room temperature for 1 hour. Incubate one control at room temperature and the other at -20 °C for 1 hour.
After incubation, combine reaction mixtures and controls with reducing SDS-PAGE sample buffer at a 1:1 (reaction mixture:sample buffer) ratio (v/v) to stop reactions.
Analyze the cleavage products by SDS-PAGE (Load 40 µL of the mixture from step 5 per lane, 1 µg Substrate per lane) followed by silver staining and/or Western blot.

Per Lane:

rBoNT/D-LC: 4 ng
Substrate: 1 µg

Reconstitution Calculator

Background: BoNT-D Light Chain

Botulinum Neurotoxin Type D is one of the seven serotypes of Botulinum Neurotoxins (BoNTs) produced by various strains of Clostridium botulinum (1, 2). BoNTs are synthesized as inactive single chain protein precursors that are activated by proteolytic cleavage to create the light and heavy chains that are linked by a disulfide bond. The 50 kDa light chain contains the metalloprotease domain whereas the 100 kDa heavy chain contains a receptor binding domain and a domain required for translocation across the cell membrane (3). BoNTs are the most toxic protein toxins known for humans. As zinc proteases, they cleave SNARE proteins to elicit flaccid paralysis in botulism poisoning. Cleavage of the SNARE proteins results in the blocking of acetylcholine release at the neuromuscular junction (2‑4). E. coli expressed recombinant light chains are active proteases. In the absence of heavy chains, however, they lack toxicity because they cannot enter into host cells.

References